Thin-film nitinol based drug eluting stent

• US 20070173787A1
• Filed: 11/01/2005
• Published: 07/26/2007
• Est. Priority Date: 11/01/2005
• Status: Abandoned Application

• Current Assignee: Cordis Corporation (Cardinal Health, Inc.)
• Original Assignee: Cordis Corporation (Cardinal Health, Inc.)
• Inventors: Sieh, Zara, Huang, Mark, McHugo, Scott, Mairal, Anurag
• Application Number:
  US11/264,582
• Publication Number:
  US 20070173787A1
• Time in Patent Office: Days
• US Class Current: 604/891.100
• CPC Class Codes: A61F 2/82 Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07; instruments specially adapted for placement or removal of stents or stent-grafts A61F2/95; for closing wounds, or holding wounds closed A61B17/04 - A61B17/115; dilators A61M29/00
• CPC Class Codes: A61F 2250/0067 Means for introducing or releasing pharmaceutical products into the body

Abstract

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism'"'"'s reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism'"'"'s reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. The drugs, agents, and/or compounds may also be utilized to treat specific diseases, including vulnerable plaque. Therapeutic agents may also be delivered to the region of a disease site. In regional delivery, liquid formulations may be desirable to increase the efficacy and deliverability of the particular drug. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In addition, the devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment. Medical devices include stents, grafts, anastomotic devices, perivascular wraps, sutures and staples. These devices may also comprise thin films that perform a number of functions. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and/or compounds from the implantable medical devices.

Claims

1. A medical device comprising:

an implantable structure having at least one surface;

a thin film mesh affixed to the at least one surface of the implantable structure; and

at least one agent, in therapeutic dosage, releasably affixed to the thin film mesh, the thin film mesh being configured to increase the surface area available for the at least one agent and release the at least one agent for a predetermined period of time.

2. A medical device comprising:

an implantable structure having at least one surface;

a thin film layer affixed to the at least one surface of the implantable structure; and

at least one agent, in therapeutic dosage, releasably affixed to the thin film, the thin film being configured as a substrate for the controlled release of the at least one agent.

3. A medical device comprising:

an implantable structure having at least one surface;

a thin film affixed to the at least one surface of the implantable structure, the thin film having a predetermined pattern of micro features in the surface thereof; and

at least one agent, in therapeutic dosage, releasably affixed to at least one of the surface of the thin film and the predetermined pattern of micro features, in the surface thereof.

4. A medical device comprising:

an implantable structure having at least one surface;

a radiopaque material layer affixed to the at least one surface of the implantable structure;

a thin film affixed to the radiopaque material layer; and

at least one agent, in therapeutic dosage, releasably affixed to the thin film.

5. A medical device comprising:

an implantable structure having at least one surface;

a radiopaque material layer affixed to the at least one surface of the implantable structure;

a thin film mesh affixed to the radiopaque material layer; and

at least one agent, in therapeutic dosage, releasably affixed to the thin film mesh.

6. A medical device comprising:

an implantable structure having at least one surface;

a thin film mesh affixed to the at least one surface of the implantable structure, the thin film mesh having a textured surface; and

at least one agent, in therapeutic dosage, releasably affixed to the thin film mesh, the thin film mesh being configured to increase the surface area available for the at least one agent and release the at least one agent for a predetermined period of time.

7. A medical device comprising:

an implantable structure having at least one surface;

a thin film layer affixed to the at least one surface of the implantable structure, the thin film layer having a textured surface; and

at least one agent, in therapeutic dosage, releasably affixed to the thin film layer, the thin film layer being configured as a substrate for the controlled release of the at least one agent.